Wegovy is one of the most effective weight loss treatments available.
In clinical trials, when used alongside diet adjustments and exercise, people using Wegovy lost an average of 14.9% vs just 2.4% in people who didn’t take Wegovy and only changed their diet and exercise.
Wegovy has been proven to reduce the relative risk of certain cardiovascular events (such as non-fatal strokes, non-fatal heart attacks and death by cardiovascular disease), by as much as 20%.
This means that Wegovy has been licensed in the UK to be used to help reduce the risk of cardiovascular issues in adults with an established cardiovascular issue.